

A practical guide for providers on helping patients locate Clenpiq, manage availability issues, and ensure successful colonoscopy preparation.
When you prescribe Clenpiq, you're choosing a bowel prep with one of the highest patient completion and satisfaction rates available. In clinical studies, 99% of patients completed the majority of the prep, and 98% said they'd take it again. But there's a recurring problem: patients can't always find it at the pharmacy.
This guide provides a practical, step-by-step approach for helping your patients navigate Clenpiq availability — from proactive prescribing to identifying alternatives when needed.
Clenpiq is manufactured solely by Ferring Pharmaceuticals. It remains a brand-only product with no generic equivalent and no competing formulation using the same active ingredients (Sodium Picosulfate, Magnesium Oxide, and Anhydrous Citric Acid).
As of early 2026, Clenpiq is not listed on the FDA Drug Shortage Database. Ferring has not reported any manufacturing or supply disruptions. However, pharmacy stocking patterns create persistent availability challenges:
For a broader supply context, see our provider briefing: Clenpiq Shortage: What Providers and Prescribers Need to Know.
Understanding the root causes helps you anticipate and address patient frustrations:
Send the Clenpiq prescription as soon as the colonoscopy is scheduled — ideally 7–14 days before the procedure date. This is the single most effective intervention. Early prescribing gives the pharmacy time to order stock and gives the patient time to troubleshoot if their first pharmacy doesn't carry it.
Before patients head to the pharmacy, recommend they verify Clenpiq availability. Medfinder for Providers is a tool designed to help patients and practices locate medications at specific pharmacies. You can also advise patients to call ahead.
Consider adding this step to your pre-procedure instructions: "Before filling your Clenpiq prescription, check availability at your pharmacy or search at medfinder.com."
If your area has independent or specialty pharmacies near your practice, build relationships with them. Independent pharmacies tend to be more responsive to special orders and may proactively stock bowel preps if they serve patients from local GI practices. They can often fulfill a Clenpiq order within 24–48 hours.
Don't wait for the patient to call in a panic the night before their procedure. Establish a standard backup protocol within your practice:
Pre-print patient instruction sheets for your top 2–3 alternative preps so you can quickly switch without creating confusion. For a patient-facing comparison: Alternatives to Clenpiq.
Clenpiq retails at approximately $252 without insurance. While most insured patients pay $20–$75 in copays, uninsured or high-deductible patients may face the full cost. Proactive cost conversations prevent no-shows:
When Clenpiq isn't available, here's a quick reference for substitutes:
All alternatives require evaluating the patient's renal function, cardiac history, and electrolyte status. For a detailed look at Clenpiq's interaction profile: Clenpiq Drug Interactions: What to Avoid.
Clenpiq's patient-friendly format makes it a top choice for colonoscopy preparation, but its single-source supply creates real workflow challenges. By prescribing early, directing patients to pharmacy-finding tools like Medfinder, maintaining relationships with reliable pharmacies, and keeping backup protocols ready, your practice can minimize cancellations and ensure patients are properly prepared.
The bottom line: a bowel prep access issue should never be the reason a patient delays colorectal cancer screening. With the right systems in place, it doesn't have to be.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.